Adjuvant treatment for elderly patients with colon cancer. An observational study

Anticancer Research

Volumn 28, Issue 4 C, 2008, Pages 2513-2518

  Pasetto, Lara Maria ^a   Falci, Cristina ^a   Basso, Umberto ^a   Gasparini, Giampietro ^b   D'Andrea, Mario ^b   Bonginelli, Paola ^b   Bajetta, Emilio ^c   Platania, Marco ^c   Alabiso, Oscar ^d   Miraglia, Stefania ^d   Bertona, Erica ^d   Oniga, Francesco ^e   Biason, Rita ^e   Chetrì, Maria Concetta ^f   Fedele, Palma ^f   Massara, Giovanna ^g   Romaniello, Incoronata ^g   Negru, Maria Emanuela ^g   Luchena, Giovanna ^h   Giordano, Monica ^h   Buzzi, Franco ⁱ   Ricotta, Riccardo ^a   Siena, Salvatore ^a   Monfardini, Silvio ^a   more..

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Istituto Nazionale per lo Studio e la Cura dei Tumori ^*

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Divisione Medica I   (Italy)

^e PERRINO HOSPITAL   (Italy)

^f SS Trinità Hospital   (Italy)

^g SANT ANNA HOSPITAL   (Italy)

^h S MARIA HOSPITAL   (Italy)

ⁱ OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Adjuvant chemotherapy; Colon cancer; Elderly

Indexed keywords

ERYTHROPOIETIN; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; OXALIPLATIN;

ADJUVANT THERAPY; AGE; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG WITHDRAWAL; EDUCATION; FEBRILE NEUTROPENIA; FEMALE; GENDER; GERIATRIC ASSESSMENT; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 48849100384     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sergent DJ, Goldberg RM, Jacobson SD et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. New Engl J Med 345(15): 1091-1097, 2001.
2. O'Connell MJ, Mailliard JA, Kahn MJ et al: Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15: 246-250, 1997.
3. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444-1450, 1990.
4. Moertel CG, Fleming TR, Macdonald JS et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358, 1990.
5. Gill S, Loprinzi CL, Sargent DJ et al: Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22: 1797-1806, 2004.
6. Mamounas E, Wieand S, Wolmark N et al: Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17: 1349-1355, 1999.
7. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 17: 1356-1363, 1999.
8. Iwashyna TJ and Lament EB: Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20: 3992-3998, 2002.
9. Schrag D, Cramer LD, Bach PB and Begg CB: Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93: 850-857, 2001.
10. Ayanian JZ, Zaslavsky AM, Fuchs CS et al: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population based cohort. J Clin Oncol 21: 1293-1300, 2003.
11. Luo R, Giordano SH, Freeman JL, Zhang D and Goodwin JS: Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist 11(9): 1025-1033, 2006.
12. Charlson ME, Pompei P, Ales KL and MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383, 1987.
13. UICC: TNM Classification of Malignant Tumours. Sixth edition. New York: Wiley-Liss 75, 2002.
14. Sargent DJ, Goldberg RM, Jacobson SD et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345: 1091-1097, 2001.
15. de Rijke JM, Schouten LJ, Scheuten HC et al: Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands. Ann Oncol 7: 677-685, 1996.
16. Bouchardy C, Queneau PE, Fioretta G et al: Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice. Br J Cancer 85: 1251-1257, 2001.
17. Sundararajan V, Grann VR, Jacobson JS et al: Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly. A population-based study. Cancer J 7: 213-218, 2001.
18. Potosky AL, Harlan LC, Kaplan RS et al: Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20: 1192-1202, 2002.
19. Kohne CH, Grothey A, Bokemeyer C et al: Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 12: 435-442, 2001.
20. Biganzoli L and Aapro M. Adjuvant chemotherapy in the elderly. Ann Oncol 14(Suppl 3): iii1-iii3, 2003.
21. Repetto L, Venturino A, Fratino L et al: Geriatric oncology, a clinical approach to the older patient with cancer. Eur J Cancer 39: 870-880, 2003.
22. Popescu RA, Norman A, Ross PJ, Parikh B and Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 17: 2412-2415, 1999.
23. Sundararajan V, Mitra N, Jacobson JS et al: Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 136: 349-357, 2002.
24. Pasetto LM, Rossi E, Jirillo A and Monfardini S: Colorectal cancer adjuvant treatment in elderly patients. Crit Rev Oncol Hematol 55(3): 201-206, 2005.
25. Lemmens VE, van Halteren AH, Janssen-Heijnen ML, Vreugdenhil G, Repelaer van Driel OJ and Coebergh JW. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 16(5): 767-772, 2005.
26. Sloan JA, Goldberg RM, Sargent DJ et al: Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 20: 1491-1498, 2002.
27. Patel K, Anthoney DA, Crellin AM et al: Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection. Ann Oncol 15: 568-573, 2004.
28. Fata F, Mirza A, Craig G et al: Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer 94: 1931-1938, 2002.
29. Satariano WA. Comorbidities and cancer. In: Hunter CP, Johnson KA and Muss HB (eds): Cancer in the Elderly. New York, NY: Marcel Dekker Inc. pp. 477-499, 2000.
30. Repetto L, Fratino L, Audisio RA et al: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20: 494-502, 2002.
31. Extermann M, Overcash J, Lyman GH et al: Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16: 1582-1587, 1998.
32. Basso U, Brunello A, Magro C, Favaretto A and Monfardini S. Overprotective caregivers of elderly cancer patients: a case report. Tumori 92(4): 362-363, 2006.